Announces concrete results of share repurchase. Total number of shares acquired recorded: 1,032,500 shares; total acquisition price: 3,877,037,500 yen. Acquisition date: 2026-11-05, executed via an off-market tender offer using ToSTNeT-3. Cumulative acquisitions to date: 1,232,500 shares, total 4,676,349,000 yen.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4547","jir_company_name":"Kissei Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-05","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/4547-20261105-01.pdf","jir_short_summary":"Announces concrete results of share repurchase. Total number of shares acquired recorded: 1,032,500 shares; total acquisition price: 3,877,037,500 yen. Acquisition date: 2026-11-05, executed via an off-market tender offer using ToSTNeT-3. Cumulative acquisitions to date: 1,232,500 shares, total 4,676,349,000 yen.","jir_summary":"### Overview of Capital Policy\nKissei Pharmaceutical Co., Ltd. implements treasury stock acquisitions to execute a flexible capital policy in response to changes in the business environment, to improve capital efficiency, and to enhance shareholder returns. The current acquisition was carried out through an off-market tender offer using ToSTNeT-3, resulting in the acquisition of 1,032,500 shares. The acquisition date was November 5, 2026, and the total acquisition amount was 3,877,037,500 yen. The cumulative number of shares acquired to date is 1,232,500 shares, and the cumulative acquisition amount is 4,676,349,000 yen.\n\n### Impact on Shareholders and Future Policy\nFuture limits on treasury stock acquisition and any additional acquisition policies are expected to be determined based on disclosed resolutions of the Board of Directors and other announcements. This measure is positioned as part of efforts to enhance shareholder returns and capital efficiency, and is considered important also from the perspective of anti-dilution measures.","jir_financial_highlights":"Total number of treasury shares acquired (this time): 1,032,500 shares (Unknown)\nTotal acquisition price of shares (this time): 3,877,037,500 yen (Unknown)\nTreasury share acquisition period (past): May 12, 2026\uff5eNovember 5, 2026 (Unknown)\nTotal number of treasury shares acquired (cumulative): 1,232,500 shares (Unknown)\nTotal acquisition price of treasury shares (cumulative): 4,676,349,000 yen (Unknown)","jir_category":"","jir_hashtags":"#KisseiPharmaceutical, #ShareBuyback","jir_key_figures":"Total number of treasury shares acquired (this time): 1,032,500 shares (total amount 3,877,037,500 yen)\nCumulative total number of shares acquired: 1,232,500 shares (cumulative total amount 4,676,349,000 yen)\nAcquisition date: 2026-11-05","jir_meta_title":"Kissei Pharmaceutical Co., Ltd. Announces Treasury Stock Acquisition\uff5cNovember 5, 2026","jir_meta_description":"Kissei Pharmaceutical Co., Ltd. announces a treasury stock acquisition. Details the number of shares acquired, total amount and implementation date, and discloses cumulative amounts to indicate capital policy trends.","jir_og_title":"Kissei Pharmaceutical Co., Ltd. Announces Treasury Stock Acquisition\uff5cNovember 5, 2026","jir_og_description":"Discloses results of treasury stock acquisition: 1,032,500 shares acquired, total 3,877,037,500 yen. Cumulative total: 1,232,500 shares, 4,676,349,000 yen. Future policy also noted.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":8930,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-141482","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n